Mount Lucas Management LP Buys Shares of 1,869 HCA Healthcare, Inc. $HCA

Mount Lucas Management LP acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,869 shares of the company’s stock, valued at approximately $716,000.

Several other hedge funds have also bought and sold shares of the stock. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare in the first quarter worth about $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the first quarter worth approximately $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new position in HCA Healthcare in the 2nd quarter worth approximately $27,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HCA. Oppenheimer upped their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Robert W. Baird increased their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Stephens upped their price objective on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Finally, KeyCorp boosted their price target on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $474.53.

HCA Healthcare Stock Performance

NYSE HCA opened at $472.40 on Monday. The company has a market cap of $107.80 billion, a P/E ratio of 18.26, a P/E/G ratio of 1.38 and a beta of 1.41. The business’s 50 day moving average price is $433.56 and its 200-day moving average price is $396.81. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $480.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.